Vaccination against Oncoproteins of HPV16 for Noninvasive Vulvar/Vaginal Lesions: Lesion Clearance Is Related to the Strength of the T-Cell ResponseMariëtte I.E. van Poelgeest, Sjoerd H. van der Burg, Marc van Beurden et al.|Clinical Cancer Research|2016Cited by 166
Supplementary Materials from Vaccination against Oncoproteins of HPV16 for Noninvasive Vulvar/Vaginal Lesions: Lesion Clearance Is Related to the Strength of the T-Cell ResponseMariëtte I.E. van Poelgeest, Sjoerd H. van der Burg, Marij J.P. Welters et al.|Unknown|2023Cited by 0
Data from Vaccination against Oncoproteins of HPV16 for Noninvasive Vulvar/Vaginal Lesions: Lesion Clearance Is Related to the Strength of the T-Cell ResponseMariëtte I.E. van Poelgeest, Sjoerd H. van der Burg, Marij J.P. Welters et al.|Unknown|2023Cited by 0
Data from Vaccination against Oncoproteins of HPV16 for Noninvasive Vulvar/Vaginal Lesions: Lesion Clearance Is Related to the Strength of the T-Cell ResponseMariëtte I.E. van Poelgeest, Sjoerd H. van der Burg, Marij J.P. Welters et al.|Unknown|2023Cited by 0
Supplementary Materials from Vaccination against Oncoproteins of HPV16 for Noninvasive Vulvar/Vaginal Lesions: Lesion Clearance Is Related to the Strength of the T-Cell ResponseMariëtte I.E. van Poelgeest, Sjoerd H. van der Burg, Marij J.P. Welters et al.|Unknown|2023Cited by 0